PF-610355
id:
pf-610355-318-9080824
title:
PF-610355
text:
PF-610355 is an inhalable ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA) that was investigated as a treatment of asthma and COPD by Pfizer. It utilizes a sulfonamide agonist headgroup, that confers high levels of intrinsic crystallinity that could relate to the acidic sulfonamide motif supporting a zwitterionic form in the solid state. Optimization of pharmacokinetic properties minimized systemic exposure following inhalation and reduced systemically mediated adverse events. Its in viv
brand slug:
wiki
category slug:
encyclopedia
description:
Respiratory medication
original url:
https://en.wikipedia.org/wiki/PF-610355
date created:
date modified:
2023-12-20T20:00:46Z
main entity:
{"identifier":"Q25104427","url":"https://www.wikidata.org/entity/Q25104427"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/d7/PF-610355.svg","width":512,"height":423}
fields total:
13
integrity:
15